In Lumpectomy For Breast Cancer, Taking Out A Bit More Reduces O.R. Revisits
In a prospective randomized trial, adding a “shave” to the lumpectomy site reduced positive margins and halved re-operations. That's huge... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 9, 2015 Category: Pharmaceuticals Authors: Elaine Schattner Source Type: news
A two year ablation nightmare – Kathi’s story
The post A two year ablation nightmare – Kathi’s story appeared first on Hysterectomy Association.
Hello everyone my name is Kathi. Although my hysterectomy is not scheduled until May 26, 2015 I wanted to share my journey with you in hopes of helping others.
In April 2014 I had an endometrial ablation done (NovaSure). It was the most horrific pain I had ever experienced. Two days after the ablation my husband rushed me to the hospital with a 104 temp and labor like pains. I was admitted and told the gyn would be giving me antibiotics intravenously. It never happened instead I was given pain meds all day and nig...
Source: The Hysterectomy Association - June 9, 2015 Category: OBGYN Authors: Linda Tags: Your Stories endometrial ablation novasure Source Type: news
A two year ablation nightmare – Kathi ’ s story
Hello everyone my name is Kathi. Although my hysterectomy is not scheduled until May 26, 2015 I wanted to share my journey with you in hopes of helping others.
In April 2014 I had an endometrial ablation done (NovaSure). It was the most horrific pain I had ever experienced. Two days after the ablation my husband rushed me to the hospital with a 104 temp and labor like pains. I was admitted and told the gyn would be giving me antibiotics intravenously. It never happened instead I was given pain meds all day and night. I was released the following day with the doctor giving no explanation for the fever and pain. I returned t...
Source: The Hysterectomy Association - June 9, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health endometrial ablation hysterectomy stories Source Type: news
A two year ablation nightmare – Kathi ’ s story
Hello everyone my name is Kathi. Although my hysterectomy is not scheduled until May 26, 2015 I wanted to share my journey with you in hopes of helping others.
In April 2014 I had an endometrial ablation done (NovaSure). It was the most horrific pain I had ever experienced. Two days after the ablation my husband rushed me to the hospital with a 104 temp and labor like pains. I was admitted and told the gyn would be giving me antibiotics intravenously. It never happened instead I was given pain meds all day and night. I was released the following day with the doctor giving no explanation for the fever and pain. I returned t...
Source: The Hysterectomy Association - June 9, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health endometrial ablation hysterectomy stories Source Type: news
Anastrozole prevents recurrence more than tamoxifen in some with noninvasive breast cancer
Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS (ductal carcinoma in situ), a common diagnosis of non-invasive breast cancer. In women over age 60, it works as well as tamoxifen. The benefit reported in this trial appeared later in follow up of the women in the study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 1, 2015 Category: Science Source Type: news
Anastrozole prevents recurrence more than tamoxifen in some with noninvasive breast cancer
(Loyola University Health System) Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS (ductal carcinoma in situ), a common diagnosis of non-invasive breast cancer. In women over age 60, it works as well as tamoxifen. These findings were presented today at the 2015 ASCO Annual Meeting in Chicago. The benefit reported in this trial appeared later in follow up of the women in the study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 30, 2015 Category: Cancer & Oncology Source Type: news
Positive Steps To Protect Yourself Against Breast Cancer
Last week, the food media celebrity Sandra Lee shared that at the age of 48 she had been diagnosed with breast cancer. She joins my rank and the rank of other celebrities, such as Martina Navratilova and Wanda Sykes, afflicted by this diagnosis. Hearing of Lee's diagnosis really hit home for me because I received the same diagnosis when I was 48. Coincidentally, we were both diagnosed with the same form of breast cancer, DCIS (Ductal Carcinoma in Situ),which is a relatively common form of the disease, and considered an early form of noninvasive breast cancer.
This type of cancer begins in the mammary ducts; however, if i...
Source: Healthy Living - The Huffington Post - May 25, 2015 Category: Consumer Health News Source Type: news
Is Genetic Testing for Breast Cancer Right for You?
Susan K. Boolbol, MD
Chief, Division of Breast Surgery
Mount Sinai Beth Israel
For most women, the average risk of developing breast cancer is about 12 percent. However, if you have a mutation on either of the two most common genes associated with breast cancer -- BRCA1 and BRCA2 -- that risk can jump as high as 80 percent. While it's natural to wonder if you might have inherited an abnormal BRCA gene from one of your parents, it's also important to remember that only about 5-10 percent of breast cancers are due to hereditary mutations; the overwhelming majority of women with breast cancer have no family history of the di...
Source: Healthy Living - The Huffington Post - May 6, 2015 Category: Consumer Health News Source Type: news
Some Women Choosing More Invasive Breast Cancer Surgery When They Don’t Need To
http://media.boston.cbslocal.com/CBSBOS_2304201517375400000AA.mp4
BOSTON (CBS) – A national study finds that even when women diagnosed with breast cancer are given the option to save their breast, many choose not to.
The new study from Brigham and Women’s Hospital had two important findings.
They found that with newer chemotherapy agents, a significant percentage of women with what is considered aggressive breast cancer, can safely opt to have a lumpectomy with radiation with outcomes just as good as if they choose to have mastectomy.
But the study also found that when women were given the option of t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 23, 2015 Category: Consumer Health News Authors: deanreddington Tags: Breast Cancer Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Angelina Jolie Brigham & Women's Hospital Dr. Mallika Marshall lumpectomy Mastectomy Study Surgery Source Type: news
No “best” treatment for common uterine fibroids
The other night, I sat in a restaurant with a group of girlfriends. We shared laughter, good conversation and some great wine. As I looked around, I realized that we were likely to share something else: uterine fibroids. Of the ten women sitting at the table, there was a good chance that seven of us would have uterine fibroids at some point in our lives.
Fibroids are noncancerous tumors that grow in the uterus. They may be smaller than a seed or bigger than a grapefruit. A woman may have only one fibroid or she may have many. Depending on their size, number, and location, fibroids can cause heavy bleeding and long menstrua...
Source: New Harvard Health Information - April 23, 2015 Category: Consumer Health News Authors: Urmila Parlikar Tags: Women's Health fibroids uterine fibroids Source Type: news
Eligible for breast conserving therapy, many still choose mastectomy
(Brigham and Women's Hospital) New research led by Brigham and Women's Hospital finds that breast conserving therapy -- or the removal of less breast tissue via a lumpectomy -- was successful in more than 90 percent of patients with triple-negative breast cancer who became eligible for this procedure after treatment with chemotherapy. Despite these findings, 31 percent who were eligible for breast conserving therapy chose to have the entire breast removed via mastectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2015 Category: Cancer & Oncology Source Type: news
New Study on Tamoxifen Efficacy
Almost every day, I hear from friends and acquaintances that I have met through BFFL Co., and I feel very fortunate to be a trusted sounding board for their questions and concerns. Here's one email I received just a few days ago from a 40-year-old premenopausal woman who has completed chemo and lumpectomy/radiation for Stage 2 breast cancer:
"Hi Elizabeth, I was curious to know your thoughts regarding this study. I am currently on tamoxifen and will be undergoing a hysterectomy by the end of the year, as per my gynecological oncologist, because I'm at higher risk now not just for recurrence of breast cancer, but other can...
Source: Healthy Living - The Huffington Post - April 1, 2015 Category: Consumer Health News Source Type: news
Director's Comments: Use of Short Term Radiation Therapy
Listen to the NLM Director's Comments on Use of Short Term Radiation Therapy. The transcript is also available.
Short term radiation treatment (following breast cancer lumpectomies) is increasing for women but most patients receive post-surgical radiation that may be twice as long as necessary, finds a comprehensive study recently published in the Journal of the American Medical Association. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - February 19, 2015 Category: Consumer Health News Source Type: news
New trial uses breast MRI and genomics for treatment decision-making in DCIS
(ECOG-ACRIN Cancer Research Group) Women with DCIS receive same treatments as those with early-stage invasive cancer. Decisions about lumpectomy/mastectomy often based on mammography alone. Trial examines whether MRIs, which show extent of disease more accurately than mammograms, help women/doctors avoid unnecessary mastectomies. Women who get lumpectomies often treated with radiation to prevent recurrence. Trial uses personalized genetic information from women's cancer tissue to identify those at low risk who may forgo radiation. Comfort/quality of life data will be collected. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2015 Category: Global & Universal Source Type: news
